Jeffrey Jerome Ludwig - 03 Mar 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: Chief Commercial Officer
Signature: /s/ Jeffrey Jerome Ludwig
Issuer symbol: PBYI
Transactions as of: 03 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 15 Mar 2022, 13:37:58 UTC
Previous filing: 05 Jan 2022
Next filing: 07 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	Common Stock	Award	$0	+39,118	+125%	$0.000000	70,460	03 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBYI	Stock Option (Right to Buy)	Award	$0	+55,882		$0.000000	55,882	03 Mar 2022	Common Stock	55,882	$2.33	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to one-fourth (1/4th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.
F2	Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.